Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study).
Expert Rev Anti Infect Ther. 2020 Dec;18(12):1271-1279. doi: 10.1080/14787210.2020.1798227. Epub 2020 Aug 14.
Expert Rev Anti Infect Ther. 2020.
PMID: 32797758
Free article.
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales.
Vena A, Giacobbe DR, Castaldo N, Cattelan A, Mussini C, Luzzati R, Rosa FG, Del Puente F, Mastroianni CM, Cascio A, Carbonara S, Capone A, Boni S, Sepulcri C, Meschiari M, Raumer F, Oliva A, Corcione S, Bassetti M.
Vena A, et al. Among authors: raumer f.
Antibiotics (Basel). 2020 Feb 9;9(2):71. doi: 10.3390/antibiotics9020071.
Antibiotics (Basel). 2020.
PMID: 32050434
Free PMC article.
Item in Clipboard
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals.
Bai F, Mazzitelli M, Silvola S, Raumer F, Restelli U, Croce D, Marchetti G, Cattelan AM.
Bai F, et al. Among authors: raumer f.
JAC Antimicrob Resist. 2023 Apr 19;5(2):dlad044. doi: 10.1093/jacamr/dlad044. eCollection 2023 Apr.
JAC Antimicrob Resist. 2023.
PMID: 37090914
Free PMC article.
Item in Clipboard
Cite
Cite